Processes for making nelfinavir mesylate
US6303786A · kind A · utility
0Cited by
23References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 28, 1999 |
| Grant date | Oct 16, 2001 |
| Priority date | — |
| Expiry date | Apr 28, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
HIV protease inhibitors inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds can be prepared by the novel methods of the present invention using the novel inventive compounds and intermediates.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.